EWTX Annual Working Capital
$310.23 M
-$30.19 M-8.87%
31 December 2023
Summary:
As of January 23, 2025, EWTX annual working capital is $310.23 million, with the most recent change of -$30.19 million (-8.87%) on December 31, 2023. During the last 3 years, it has risen by +$184.92 million (+147.58%). EWTX annual working capital is now -8.87% below its all-time high of $340.41 million, reached on December 31, 2022.EWTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EWTX Quarterly Working Capital
$480.48 M
-$21.79 M-4.34%
30 September 2024
Summary:
As of January 23, 2025, EWTX quarterly working capital is $480.48 million, with the most recent change of -$21.79 million (-4.34%) on September 30, 2024. Over the past year, it has increased by +$198.90 million (+70.63%). EWTX quarterly working capital is now -8.80% below its all-time high of $526.83 million, reached on March 31, 2024.EWTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EWTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.9% | +70.6% |
| 3 y3 years | +147.6% | +70.6% |
| 5 y5 years | +1254.0% | +70.6% |
EWTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.9% | +13.5% | -8.8% | +96.8% |
| 5 y | 5-year | -8.9% | +1254.0% | -8.8% | +283.4% |
| alltime | all time | -8.9% | +1254.0% | -8.8% | +283.4% |
Edgewise Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $480.48 M(-4.3%) |
| June 2024 | - | $502.26 M(-4.7%) |
| Mar 2024 | - | $526.83 M(+69.8%) |
| Dec 2023 | $310.23 M(-8.9%) | $310.23 M(+10.2%) |
| Sept 2023 | - | $281.58 M(-6.9%) |
| June 2023 | - | $302.60 M(-5.6%) |
| Mar 2023 | - | $320.65 M(-5.8%) |
| Dec 2022 | $340.41 M | $340.41 M(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $356.84 M(+46.2%) |
| June 2022 | - | $244.13 M(-5.6%) |
| Mar 2022 | - | $258.61 M(-5.4%) |
| Dec 2021 | $273.25 M(+118.1%) | $273.25 M(-3.9%) |
| Sept 2021 | - | $284.49 M(-4.0%) |
| June 2021 | - | $296.23 M(-3.1%) |
| Mar 2021 | - | $305.69 M(+144.0%) |
| Dec 2020 | $125.30 M(+446.9%) | $125.30 M |
| Dec 2019 | $22.91 M | - |
FAQ
- What is Edgewise Therapeutics annual working capital?
- What is the all time high annual working capital for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual working capital year-on-year change?
- What is Edgewise Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly working capital year-on-year change?
What is Edgewise Therapeutics annual working capital?
The current annual working capital of EWTX is $310.23 M
What is the all time high annual working capital for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual working capital is $340.41 M
What is Edgewise Therapeutics annual working capital year-on-year change?
Over the past year, EWTX annual working capital has changed by -$30.19 M (-8.87%)
What is Edgewise Therapeutics quarterly working capital?
The current quarterly working capital of EWTX is $480.48 M
What is the all time high quarterly working capital for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly working capital is $526.83 M
What is Edgewise Therapeutics quarterly working capital year-on-year change?
Over the past year, EWTX quarterly working capital has changed by +$198.90 M (+70.63%)